Master of Science Graduates
Six students will be awarded the degree Master of Science after completing their final master's project in the RNA Splicing and Disease Research Group.
The 17th of June Ida Emilie Jørgensen defended her master's project with the title 'Investigation of the RNA-binding protein RBM12 and disease-associated missense mutations in RNA-binding domains of RBM12.
Inverna Therapeutics
Inverna Therapeutics was established in 2025 based on research done in RNA splicing and disease research group.